José Javier Sánchez

16.1k total citations · 1 hit paper
90 papers, 6.0k citations indexed

About

José Javier Sánchez is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, José Javier Sánchez has authored 90 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Pulmonary and Respiratory Medicine, 42 papers in Oncology and 35 papers in Molecular Biology. Recurrent topics in José Javier Sánchez's work include Lung Cancer Treatments and Mutations (41 papers), Cancer Genomics and Diagnostics (20 papers) and Lung Cancer Research Studies (17 papers). José Javier Sánchez is often cited by papers focused on Lung Cancer Treatments and Mutations (41 papers), Cancer Genomics and Diagnostics (20 papers) and Lung Cancer Research Studies (17 papers). José Javier Sánchez collaborates with scholars based in Spain, United States and Italy. José Javier Sánchez's co-authors include Rafael Rosell, Miquel Tarón, Carlos Camps, Enriqueta Felip, José Miguel Sánchez, Vicente Alberola, J Maestre, Dolores Isla, Rafael Rosell and Kathleen D. Danenberg and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

José Javier Sánchez

87 papers receiving 5.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer.

2002 551 citations Carlos Camps, Manuel Dómine et al. profile →

Peers

Countries citing papers authored by José Javier Sánchez

Since Specialization

Citations

This map shows the geographic impact of José Javier Sánchez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José Javier Sánchez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José Javier Sánchez more than expected).

Fields of papers citing papers by José Javier Sánchez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José Javier Sánchez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José Javier Sánchez. The network helps show where José Javier Sánchez may publish in the future.

Co-authorship network of co-authors of José Javier Sánchez

This figure shows the co-authorship network connecting the top 25 collaborators of José Javier Sánchez. A scholar is included among the top collaborators of José Javier Sánchez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José Javier Sánchez. José Javier Sánchez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sustainable biobased epoxy thermosets with covalent dynamic imine bonds for green composite development 2023 ·Polymer ·(unknown), Miren Blanco, Nerea Uranga, José Javier Sánchez, José Manuel Laza, (unknown), Estíbaliz Aranzabe	20
2	BRCA1, LMO4, and CtIP mRNA Expression in Erlotinib-Treated Non–Small-Cell Lung Cancer Patients with EGFR Mutations 2013 ·Journal of Thoracic Oncology ·Niki Karachaliou, Carlota Costa, Ana Giménez‐Capitán, Miguel Ángel Molina‐Vila, Jordi Bertrán-Alamillo, Clara Mayo, Bartomeu Massutí, Margarita Majem, Enric Carcereny, Teresa Morán, José Javier Sánchez, Santiago Viteri, Amaya Gascó, Luciano Wannesson, John Souglakos, José Jimeno, Rafael Rosell	15
3	Polymorphisms in HIF-1alpha affect presence of lymph node metastasis and can influence tumor size in squamous-cell carcinoma of the glottic larynx 2012 ·Clinical & Translational Oncology ·(unknown), (unknown), (unknown), (unknown), (unknown), José Javier Sánchez, Miguel Quintanilla, L. Cerezo, Carlos Gamallo	17
4	A Combined Strategy of SAGE and Quantitative PCR Provides a 13-Gene Signature that Predicts Preoperative Chemoradiotherapy Response and Outcome in Rectal Cancer 2011 ·Clinical Cancer Research ·E. Casado, Víctor Moreno, José Javier Sánchez, Montserrat Blanco, Joan Maurel, Jaime Feliú, Carlos Fernández-Martos, Javier de Castro, Beatriz Castelo, Cristóbal Belda-Iniesta, María Sereno, (unknown), Emilio Burgos, Miguel Ángel García‐Cabezas, Noemí Manceñido, Rosa Miquel, Damián García‐Olmo, Manuel González-Barón, Paloma Cejas	25
5	Circulating DNA is a Useful Prognostic Factor in Patients with Advanced Non-small Cell Lung Cancer 2011 ·Journal of Thoracic Oncology ·Rafael Sirera, Roy M. Bremnes, Andrea Cabrera‐Pastor, Eloísa Jantus‐Lewintre, Elena Sanmartín, Ana Blasco, (unknown), Rafael Rosell, R. Guijarro, José M. Galbis, José Javier Sánchez, Carlos Camps	69
6	Prognostic value of carcinoembryonic antigen level in rectal cancer treated with neoadjuvant chemoradiotherapy 2009 ·International Journal of Colorectal Disease ·Víctor Moreno, Paloma Cejas, (unknown), Jaime Feliú Batlle, Javier de Castro, Cristóbal Belda-Iniesta, Jorge Barriuso, José Javier Sánchez, J Larrauri, M. González‐Barón, Enrique Casado	47
7	Three-Gene Expression Signature Predicts Survival in Early-Stage Squamous Cell Carcinoma of the Lung 2008 ·Clinical Cancer Research ·Marcin Skrzypski, Ewa Jassem, Miquel Tarón, José Javier Sánchez, Pedro Méndez, Witold Rzyman, (unknown), Dan J. Raz, David M. Jablons, Mariano Provencio, Bartomeu Massutí, Imane Chaib, Laia Perez‐Roca, Jacek Jassem, Rafael Rosell	84
8	ERCC1 mRNA levels and survival of advanced gastric cancer patients treated with a modified FOLFOX regimen 2008 ·British Journal of Cancer ·Jia Wei, Zhengyun Zou, Xiaoping Qian, Yitao Ding, Li Xie, José Javier Sánchez, Yang Zhao, J. Feng, Ling Ye, (unknown), Lixia Yu, Rafael Rosell, (unknown)	58
9	B2-01: The NATCH trial: chemotherapy toxicity and response on the neoadjuvant arm 2007 ·Journal of Thoracic Oncology ·Enriqueta Felip, Rafael Rosell, Bartomeu Massutí, Guillermo Alonso, J.L. González-Larriba, Carlos Camps, Dolores Isla, (unknown), José Javier Sánchez, J Maestre	1
10	Expression of choline kinase alpha to predict outcome in patients with early-stage non-small-cell lung cancer: a retrospective study 2007 ·The Lancet Oncology ·Ana Ramı́rez de Molina, Jacinto Sarmentero, Cristóbal Belda-Iniesta, Miquel Tarón, (unknown), Paloma Cejas, Marcin Skrzypski, David Gallego‐Ortega, Javier de Castro, Enrique Casado, Miguel Ángel García‐Cabezas, José Javier Sánchez, Manuel Nistal, Rafael Rosell, Manuel González-Barón, Juan Carlos Lacal	130
11	Analysis of c-kit expression in small cell lung cancer: Prevalence and prognostic implications 2006 ·Lung Cancer ·Carlos Camps, Rafael Sirera, Roy M. Bremnes, J. Garde, María José Safont, Ana Blasco, Alfonso Berrocal, José Javier Sánchez, (unknown), Miguel Martorell	22
12	Clinical Significance of Hypoxia-Inducible Factor–1α Messenger RNA Expression in Locally Advanced Non–Small-Cell Lung Cancer After Platinum Agent and Gemcitabine Chemotherapy Followed by Surgery 2005 ·Clinical Lung Cancer ·Enriqueta Felip, Miquel Tarón, Rafael Rosell, Pedro Méndez, Cristina Queralt, M. Sánchez Ronco, José Javier Sánchez, José Miguel Sánchez, J Maestre, Joaquim Majó Fernández	5
13	β-Catenin, Nf-κB and FAS protein expression are independent events in head and neck cancer: study of their association with clinical parameters 2005 ·Cancer Letters ·María Rodríguez‐Pinilla, José Luis Rodríguez‐Peralto, Ricardo Hitt, José Javier Sánchez, L Sánchez‐Verde, F. Alameda, Claudio Ballestı́n, Montse Sánchez‐Céspedes	16
14	Is there a prognostic role of K-ras point mutations in the serum of patients with advanced non-small cell lung cancer? 2005 ·Lung Cancer ·Carlos Camps, Rafael Sirera, Roy M. Bremnes, Ana Blasco, (unknown), (unknown), María José Safont, José Javier Sánchez, Miquel Tarón, Rafael Rosell	42
15	Single nucleotide polymorphisms and outcome in docetaxel–cisplatin-treated advanced non-small-cell lung cancer 2004 ·Annals of Oncology ·Dolores Isla, Carme Sarries, Rafael Rosell, G. Alonso, Manuel Dómine, Miquel Tarón, Guillermo López-Vivanco, Carlos Camps, Mónica Botia, L. Núñez, M. Sánchez-Ronco, José Javier Sánchez, M. López-Brea, I. Barneto, Alfredo Paredes, (unknown), Á. Artal, P. Lianes	255
16	Assessment of Nucleotide Excision Repair XPD Polymorphisms in the Peripheral Blood of Gemcitabine/Cisplatin–Treated Advanced Non–Small-Cell Lung Cancer Patients 2003 ·Clinical Lung Cancer ·Carlos Camps, (unknown), Bárbara Roig, José Javier Sánchez, Cristina Queralt, (unknown), Natividad Martínez-Banaclocha, Miguel Tarón, Rafael Rosell	42
17	Phase II non-randomized study of three different sequences of docetaxel and vinorelbine in patients with advanced non-small cell lung cancer 2002 ·Lung Cancer ·José Miguel Sánchez, Carmen Balañá, Albert Font, José Javier Sánchez, José Luís Zamora Manzano, (unknown), Mireia Margelí Vila, Martin Eduardo Richardet, Rafael Rosell	11
18	The role of chemotherapy in early non-small-cell lung cancer management 2001 ·Lung Cancer ·R. Rosell, Enriqueta Felip, J Maestre, José Miguel Sánchez, José Javier Sánchez, José Luís Zamora Manzano, Julio Astudillo, (unknown), Mariano Monzó	22
19	Acute and anticipatory emesis in breast cancer patients 1996 ·Supportive Care in Cancer ·(unknown), Miguel Martín, (unknown), Antonio Casado, José A. López-Martín, Eduardo Díaz‐Rubio, José Javier Sánchez	17
20	Serum albumin and other prognostic factors related to response and survival in patients with advanced non-small cell lung cancer 1995 ·Lung Cancer ·Enrique Espinosa, Jaime Feliú, P. Zamora, Manuel González Barón, José Javier Sánchez, A. Ordóñez, Javier Espinosa	108

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact